Semuloparin (AVE-5026)
Revision as of 13:54, 15 September 2022 by Warner-admin (talk | contribs) (Text replacement - "https://www.nejm.org/doi/full/10.1056" to "https://doi.org/10.1056")
General information
Class/mechanism: Hemisynthetic ultra low molecular weight heparin (ULMWH), binds to antithrombin III, accelerating its activity and inhibiting factor Xa, factor IIa, and thrombin.[1][2]
Route: SC
Extravasation: n/a
Patient drug information
No information available.
Also known as
- Code name: AVE5026
References
- ↑ Semuloparin (AVE5026) manufacturer's website
- ↑ Agnelli G, George DJ, Kakkar AK, Fisher W, Lassen MR, Mismetti P, Mouret P, Chaudhari U, Lawson F, Turpie AG; SAVE-ONCO Investigators. Semuloparin for thromboprophylaxis in patients receiving chemotherapy for cancer. N Engl J Med. 2012 Feb 16;366(7):601-9. link to original article PubMed